Tyra Biosciences Investor Relations Material
Latest events
Study Update
Tyra Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Tyra Biosciences Inc
Access all reports
Tyra Biosciences Inc. is a clinical-stage biotechnology company specializing in the development of precision medicines targeted at Fibroblast Growth Factor Receptor biology. Leveraging its proprietary platform, Tyra Biosciences focuses on creating drugs through iterative molecular snapshots which aid in predicting genetic alterations and developing therapies for oncology and genetically defined conditions. The company is headquartered in Carlsbad, California, and its shares are listed on the NASDAQ.
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
TYRA
Country
🇺🇸 United States